Citation

Montgomery SA, Gabriel R, James D, Hawley C, Burkitt P. Int. Clin. Psychopharmacol. 1989; 4(1): 19-23.

Affiliation

St Mary's Hospital Medical School, London.

Copyright

(Copyright © 1989, Lippincott Williams and Wilkins)

DOI

unavailable

PMID

2531772

Abstract

The first of a series of 5HT reuptake inhibitors, zimelidine was withdrawn because of associated hypersensitivity reactions. There was concern that such reactions might be seen with other compounds of this class. Two depressed patients who had a sensitivity reaction to treatment with zimelidine were crossed over to treatment with fluoxetine and no abnormalities were observed. Both patients remained well during uneventful long term treatment with fluoxetine.

Language: en